GNH USA

Europe — EMA

Memantina Flas Stada

GNH USA supplies Memantina Flas Stada (Memantine), a NMDA receptor antagonist for Alzheimer's disease. Request a quote for global supply to qualified buyers.

Memantine

Request sourcing

1
Pack/s

What is Memantine?

Memantine, the active ingredient in Memantina Flas Stada, is a NMDA receptor antagonist presented as an oral formulation for oral use. It is used to treat cognitive symptoms of Alzheimer’s disease in adults. GNH USA supplies Memantina Flas Stada as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

What is Memantine used for?

Memantine acts on the glutamatergic pathway and is indicated for Alzheimer’s disease. - Alzheimer’s disease (mild to moderate): improves cognition and daily functioning. - Alzheimer’s disease (moderate to severe): helps maintain functional abilities and slows decline. - Alzheimer’s disease with behavioral disturbances: may reduce agitation and improve overall patient management.

What are the side effects of Memantine?

Memantine may be associated with several adverse reactions.

Common Side Effects: - Dizziness: sensation of light‑headedness or unsteadiness. - Headache: mild to moderate intensity. - Constipation: reduced bowel movements. - Fatigue: feeling unusually tired. - Hypertension: elevated blood pressure readings. - Confusion: transient mental clouding.

Serious or Rare Side Effects: - Seizures: occurrence of convulsive episodes. - Cardiac arrhythmia: irregular heart rhythm. - Severe skin reactions: such as Stevens‑Johnson syndrome. - Hepatic dysfunction: signs of liver injury. - Suicidal ideation: thoughts of self‑harm. - Severe rash: widespread or blistering skin eruption.

What precautions apply to Memantine?

When prescribing Memantina Flas Stada, consider the following precautions. - Renal impairment: assess kidney function and adjust dose if needed. - History of seizures: monitor for increased seizure activity. - Cardiovascular disease: observe blood pressure and heart rhythm. - Concomitant NMDA agonists: avoid combined use due to additive effects. - Pregnancy: risk unknown; use only if potential benefit justifies the risk. - Store at ambient temperature: keep in the original container, protect from moisture and direct sunlight.

What does Memantine interact with?

Memantine can interact with several medicines; awareness of the interaction level is important.

Major Interactions (Avoid): - Amantadine: additive NMDA antagonism may increase neurotoxicity. - Ketamine: combined CNS depression risk. - Mefloquine: potential for enhanced neuropsychiatric effects.

Moderate Interactions (Monitor Closely): - Antihypertensives: may potentiate hypotensive response. - Diuretics: possible electrolyte disturbances. - Anticholinergics: may increase confusion and cognitive impairment.

Frequently asked questions

What is Memantina Flas Stada used for?+
Memantina Flas Stada contains memantine, which is prescribed to treat cognitive decline and functional impairment associated with Alzheimer’s disease. It is used in adults with mild to severe forms of the condition to help maintain daily activities and slow disease progression.
How does memantine work in the brain?+
Memantine acts as a non‑competitive antagonist at the NMDA receptor, reducing excessive calcium influx caused by overstimulation of glutamate. This modulation protects neurons from excitotoxic damage, helping to preserve synaptic function and mitigate the neurodegenerative processes seen in Alzheimer’s disease.
What is the usual dose of Memantina Flas Stada?+
The specific dose of Memantina Flas Stada is determined by the prescribing physician based on the patient’s clinical condition, age, renal function, and response to therapy. Dosage adjustments are made individually and should follow the prescriber’s instructions.
Is Memantina Flas Stada safe during pregnancy or breastfeeding?+
Safety data for memantine in pregnancy and lactation are limited. It should only be used if the potential benefit to the mother outweighs any possible risk to the fetus or infant, and this decision must be made by a qualified healthcare professional.
How do I order Memantina Flas Stada from GNH USA?+
To place an order, submit an enquiry on the product page at gnh-usa.com specifying the required quantity. GNH USA works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.
How does memantine compare with other Alzheimer’s treatments?+
Memantine belongs to the NMDA receptor antagonist class, differing from cholinesterase inhibitors such as donepezil. While cholinesterase inhibitors increase acetylcholine levels, memantine reduces glutamate‑mediated excitotoxicity. In practice, memantine may be used alone or in combination with a cholinesterase inhibitor for additive benefit.
What are the storage requirements for Memantina Flas Stada?+
Memantina Flas Stada should be stored at ambient temperature, below 25 °C. Keep the product in its original packaging, protect it from moisture and direct sunlight, and ensure the container is tightly closed to maintain stability.
How is Memantina Flas Stada administered?+
The medication is taken orally, usually with or without food, as directed by the prescriber. Tablets (or oral solution, if applicable) should be swallowed whole and not crushed or chewed unless specifically instructed by a healthcare professional.
What are the most serious risks associated with memantine?+
Serious adverse events, though uncommon, include seizures, cardiac arrhythmias, severe skin reactions such as Stevens‑Johnson syndrome, hepatic dysfunction, and emergence of suicidal thoughts. Patients should be monitored closely for any of these signs and seek immediate medical attention if they occur.
Who should not use Memantina Flas Stada?+
Memantina Flas Stada is contraindicated in patients with known hypersensitivity to memantine or any of the product’s excipients. Caution is advised for individuals with severe renal impairment, uncontrolled hypertension, or a history of seizures, and it should be avoided in those where the risk outweighs potential benefit.
Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.

Product details

Drug
Memantine
Route
Oral Use
Manufacturer
Laboratorio Stada, S.L.
Origin
EU

Related products